


- Clinical need
- About MicroRNAs
- Test technology
- How the test is performed
- For which patients
- Results overview
- Today's diagnostic solution
- How to order
- News and publications
- miRview® home











About MicroRNAs
|
The significance of microRNAs in cancer diagnostics MicroRNAs are small 20-22 nucleotide, noncoding RNA genes that regulate gene expression at the translational level1. Some microRNA may have as many as a few thousand targets and between 74% and 92% of the gene transcripts in four model organisms are likely under microRNA control2. Over the last decade, our knowledge about the role of microRNA in human diseases, including cancer, has grown exponentially3,4. Alteration in the expression of microRNA genes contribute to the pathogenesis of most if not all human malignancies3,5,6. MicroRNAs can act as oncogenes or tumor suppressors7. In our miRview® lung test, microRNAs serve as useful biomarkers for lung cancer diagnosis. In the near future microRNAs will probably play a pivotal role in cancer therapy and prevention. Using proprietary methods developed by Rosetta Genomics' scientists, microRNAs can be extracted from a wide range of tissue and body fluid samples and quantified to identify a specific microRNA signature. MicroRNAs have been found to be well preserved in various types of clinical samples and preparations, and their levels can be accurately quantified by molecular assays2. MicroRNA may provide the solution for classification accuracy and objectivity for classification accuracy and objectivity.
|